Latest updates for Aav:ca

Fresh curated links around AAV:CA are collected here so marketers can spot useful updates and turn timely ideas into posts faster.

Recent items include:

  • Engineered helper plasmid boosts AAV production by tuning E4orf6 and L4-22/33K expression
  • Evaxion Presents New Preclinical Data for AI-Designed CMV Vaccine Program EVX-V1
  • Atea outlines peak annual U.S. net revenue potential in excess of $700M with focus on mid-2028 HCV launch

Post angles to try

Share the most useful takeaway for your audience.
Turn one article into a quick practical checklist.
Ask your audience how this shift affects their work.
Turn angles into scheduled posts

Fresh articles and ideas

Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.

bioengineer.org /1 month ago

Engineered helper plasmid boosts AAV production by tuning E4orf6 and L4-22/33K expression

A redesigned helper plasmid has increased the production of adeno-associated virus (AAV) vectors by controlling the relative expression of two adenoviral regulatory factors, accord...

Read source
hearingreview.com /1 month ago

Evaxion Presents New Preclinical Data for AI-Designed CMV Vaccine Program EVX-V1

New preclinical findings show AI-discovered T-cell epitopes may improve control of CMV infection.

Read source
seekingalpha.com /3 weeks ago

Atea outlines peak annual U.S. net revenue potential in excess of $700M with focus on mid-2028 HCV launch

Read source

Turn fresh research into a full content calendar

Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.

Sources covering Aav:ca

bioengineer.org

Recent coverage from public sources
Public source

seekingalpha.com

Recent coverage from public sources
Public source

hearingreview.com

Recent coverage from public sources
Public source